Dr. Rena A. Stathacopoulos, MD

Dr. Stathacopoulos practices at San Luis Obispo Eye Associates, a Medical Group Inc. in San Luis Obispo, California.

Dr. Stathacopoulos' NPI, 1881609238, was assigned on July 31, 2006. Dr. Stathacopoulos graduated from David Geffen School of Medicine at UCLA in 1987. Dr. Stathacopoulos holds California license G65410.

Dr. Stathacopoulos' primary practice is San Luis Obispo Eye Associates, a Medical Group Inc., at 689 Tank Farm Rd, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (805) 781-3937.

Dr. Stathacopoulos' primary practice is San Luis Obispo Eye Associates, a Medical Group Inc. in San Luis Obispo, California. Dmand AI also links Dr. Stathacopoulos to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stathacopoulos practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Stathacopoulos' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Stathacopoulos is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Stathacopoulos is licensed in California.

Dmand AI lists eyelid inflammation and vision problems among the conditions Dr. Stathacopoulos treats.

CMS data shows 31 Medicare services from Dr. Stathacopoulos across 2 procedure codes in 2024, for 17 Medicare patients. Medicare paid $2,169 for them. Every service was in an office.

CMS counts 17 Medicare patients who saw Dr. Stathacopoulos in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stathacopoulos' median patient age at 10, with 47% women.

In 2020, Dr. Stathacopoulos wrote 16 Medicare Part D claims. They cover 1 drug, with $185 in total drug cost. In 2019, CMS named 41 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Stathacopoulos for performance year 2024, reported as part of a group. Dr. Stathacopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Stathacopoulos. Dr. Stathacopoulos' most frequent co-authors are David Richard Stager, MD and Anne Jennifer Ziffer, MD.

CMS Open Payments shows 14 general payments to Dr. Stathacopoulos from 6 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 86% of the total. Alcon Laboratories Inc paid the most, $369.

Dmand AI lists 2 awards for Dr. Stathacopoulos, most recently CMS Stage 1 2012 in 2011.

Dr. Stathacopoulos graduated from David Geffen School of Medicine at UCLA in 1987. Dr. Stathacopoulos is a member of AAO.

Dr. Stathacopoulos is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.